ArticleJournal of Cancer2021

High Expression of RhoF Predicts Worse Overall Survival: A Potential Therapeutic Target for non-M3 Acute Myeloid Leukemia.

Yue Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.